HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mercedes Gonzalez-Juarrero Selected Research

Spectinomycin (Spectinomycin Hydrochloride)

1/2019Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice.
2/2014Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mercedes Gonzalez-Juarrero Research Topics

Disease

20Infections
01/2020 - 12/2002
18Tuberculosis (Tuberculoses)
10/2021 - 12/2002
4Pulmonary Tuberculosis
01/2016 - 12/2002
4Granuloma
06/2015 - 06/2005
3Pneumonia (Pneumonitis)
07/2010 - 08/2005
2Lung Diseases (Lung Disease)
01/2020 - 07/2010
2Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2018 - 01/2016
2Foreign Bodies (Foreign Body)
09/2015 - 07/2009
1Hypoxia (Hypoxemia)
01/2022
1COVID-19
04/2021
1Cystic Fibrosis (Mucoviscidosis)
01/2020
1Infertility (Sterility)
01/2019
1Necrosis
06/2015
1Leprosy (Hansen's Disease)
12/2014
1Pulmonary Fibrosis (Fibrosing Alveolitis)
08/2014
1Weight Gain
04/2014
1Extensively Drug-Resistant Tuberculosis
02/2014
1Melioidosis
12/2013
1Acquired Immunodeficiency Syndrome (AIDS)
02/2012
1Inflammation (Inflammations)
07/2010
1Persistent Infection
10/2008
1Disease Progression
10/2008

Drug/Important Bio-Agent (IBA)

8AerosolsIBA
09/2019 - 04/2006
7Pharmaceutical PreparationsIBA
10/2020 - 06/2010
5CytokinesIBA
01/2018 - 12/2002
4VaccinesIBA
01/2020 - 11/2007
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2014 - 06/2005
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 02/2014
3Interleukin-10 (Interleukin 10)IBA
03/2009 - 12/2002
2Oxygen (Dioxygen)IBA
01/2022 - 11/2011
2Spectinomycin (Spectinomycin Hydrochloride)FDA Link
01/2019 - 02/2014
2Biocompatible Materials (Biomaterials)IBA
09/2015 - 07/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2009 - 04/2006
1Lipid NanoparticlesIBA
04/2021
1Excipients (Suspending Agents)IBA
04/2021
1Mutant Proteins (Protein, Mutant)IBA
10/2020
1Vitamin K 2 (Vitamin K2)IBA
10/2020
1Oxidoreductases (Dehydrogenase)IBA
10/2020
1Tigecycline (Tygacil)FDA Link
01/2020
1BCG VaccineFDA Link
01/2020
1Antitubercular AgentsIBA
01/2019
1Methanol (Carbinol)IBA
01/2019
1Peptides (Polypeptides)IBA
11/2018
1MitogensIBA
08/2018
1AmidesIBA
01/2018
1benzothiazoleIBA
01/2018
1Platelet Endothelial Cell Adhesion Molecule-1IBA
08/2014
1Bacterial Proteins (Bacterial Protein)IBA
02/2014
1Amikacin (A.M.K)FDA LinkGeneric
07/2012
1Isoniazid (Ftivazide)FDA LinkGeneric
07/2012
1Capreomycin (Capastat)FDA Link
07/2012
1Interleukin-4 (Interleukin 4)IBA
07/2010
1Butylated Hydroxytoluene (BHT)IBA
07/2010
1ArginaseIBA
07/2010
1Macrophage Colony-Stimulating FactorIBA
04/2008
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
09/2005
1DNA (Deoxyribonucleic Acid)IBA
08/2005
1Interleukin-2 (IL2)IBA
12/2002
1Transforming Growth Factor beta (TGF-beta)IBA
12/2002

Therapy/Procedure

6Therapeutics
10/2021 - 02/2012
3Drug Therapy (Chemotherapy)
01/2018 - 12/2014
1RNAi Therapeutics
01/2016